The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 37, No. 3, pp. 433-437. DOI 10.1345/aph.1C115
© 2003 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huggins, R. M
Right arrow Articles by Latour, J. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggins, R. M
Right arrow Articles by Latour, J. K

DRUG INFORMATION ROUNDS

Intravenous Proton-Pump Inhibitors Versus H2-Antagonists for Treatment of GI Bleeding

Rebecca M Huggins, PharmD

at time of writing, Pharmacy Practice Resident, Department of Pharmacy, Duke University Medical Center, Durham, NC; now, Critical Care Pharmacist, Palmetto Richland Memorial Hospital, Columbia, SC

Ann C Scates, PharmD

Clinical Pharmacist — Drug Information, Department of Pharmacy, Duke University Medical Center

Joanne K Latour, PharmD

Clinical Pharmacist — Medical Intensive Care Unit, Department of Pharmacy, Duke University Medical Center

Reprints: Ann C Scates PharmD, Department of Pharmacy, Duke University Medical Center, DUMC Box 3089, Durham, NC 27710-0001, FAX 919/681-3895, E-mail ann.scates{at}duke.edu

OBJECTIVE: To evaluate the evidence supporting the use of intravenous proton-pump inhibitors in the treatment of gastrointestinal (GI) hemorrhage in comparison with histamine2 (H2)-receptor antagonists.

DATA SOURCES: Clinical literature was accessed through a MEDLINE search (1966–October 2002). Data from abstracts and fully published articles were retrieved for analysis. Key search terms included pantoprazole, omeprazole, proton-pump inhibitors, gastrointestinal hemorrhage, histamine2-receptor antagonists, ranitidine, and cimetidine.

DATA SYNTHESIS: There are limited published clinical outcome data evaluating the use of intravenous pantoprazole in patients with upper GI hemorrhage. However, there are several gastric pH studies suggesting that intravenous pantoprazole is effective in quickly obtaining and maintaining a pH >6. When considering the results from studies of high-dose intravenous omeprazole, in addition to the pantoprazole data, the relative efficacy of intravenous proton-pump inhibitors appears to be superior to that of intravenous H2-receptor antagonists in providing a more predictable and sustained pH control.

CONCLUSIONS: Intravenous proton-pump inhibitors are suitable, possibly superior, alternatives to intravenous H2-receptor antagonists in treatment of upper GI bleeding.

Key Words: gastrointestinal hemorrhage, histamine2-receptor antagonists, proton-pump inhibitors

Published Online, January 27, 2003. www.theannals.com, DOI 10.1345/aph.1C115


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P.-I Hsu, C.-H. Chen, C.-S. Hsieh, W.-C. Chang, K.-H. Lai, G.-H. Lo, P.-N. Hsu, F.-W. Tsay, Y.-S. Chen, M. Hsiao, et al.
{alpha}1-Antitrypsin Precursor in Gastric Juice Is a Novel Biomarker for Gastric Cancer and Ulcer
Clin. Cancer Res., February 1, 2007; 13(3): 876 - 883.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2003 by Harvey Whitney Books Company.